Trial NCT04350684
Publication Alavi Darazam I (2), Int Immunopharmacol, 2021
Primary outcome on the report: Improvement of two points of the seven-category ordinal scale or discharge from the hospital, whichever comes first.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.